Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.01 | N/A |
| PEG Ratio (TTM) | 0.00 | N/A |
| P/S Ratio (TTM) | 0.01 | N/A |
| P/B Ratio (TTM) | -0.01 | N/A |
| P/FCF Ratio (TTM) | 0.08 | N/A |
| Price to 5YR AVG Earnings Ratio | -0.07 | N/A |
| Price to 5YR AVG FCF Ratio | 0.01 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -11.63% | N/A |
| ROE (TTM) | 56.42% | N/A |
| Net Profit Margin (TTM) | -52.37% | N/A |
| ROIC 5YR AVG | 6.21% | N/A |
Growth (67%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 13.24% | 180.88% | 16.50% |
| Revenue | 7.72% | -8.02% | -3.98% |
| Net Income | 12.66% | 183.94% | 19.08% |
| Cash Flow | 429.24% | -12.08% | -26.58% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.07 | N/A |
| Quick Ratio (TTM) | 2.07 | N/A |
| D/E Ratio (TTM) | -4.72 | N/A |
| Interest Coverage (TTM) | 0.80 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.32 | N/A |
| LTL to 5YR AVG FCF | 6.37 | N/A |
| Shares Outstanding Growth 5YR AVG | -2.09% | N/A |